Dual anti-platelet therapy after coronary artery bypass grafting: Is there any benefit? A systematic review and meta-analysis

Journal of Cardiac Surgery

Volumn 28, Issue 2, 2013, Pages 109-116

  Deo, Salil V ^a,b   Dunlay, Shannon M ^a   Shah, Ishan K ^a   Altarabsheh, Salah E ^a,c   Erwin, Patricia J ^a   Boilson, Barry A ^a   Park, Soon J ^a   Joyce, Lyle D ^a  

^a MAYO CLINIC   (United States)

^b Adventist Wockhardt Heart Hospital   (India)

^c Princess Alia Heart Institute   (Jordan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; PLACEBO;

ACUTE CORONARY SYNDROME; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ANTICOAGULANT THERAPY; BLEEDING; CARDIOVASCULAR RISK; CORONARY ARTERY BYPASS GRAFT; GRAFT OCCLUSION; GRAFT PATENCY; HEART INFARCTION; HUMAN; INTRAOPERATIVE PERIOD; META ANALYSIS; MONOTHERAPY; MORTALITY; MULTIDETECTOR COMPUTED TOMOGRAPHY; OFF PUMP CORONARY SURGERY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SAPHENOUS VEIN GRAFT; SYSTEMATIC REVIEW;

EID: 84875124713     PISSN: 08860440     EISSN: 15408191     Source Type: Journal    
DOI: 10.1111/jocs.12074     Document Type: Review

References (24)

1. Motwani JG, Topol EJ:, Aortocoronary saphenous vein graft disease: Pathogenesis, predisposition, and prevention. Circulation 1998; 97 (9): 916-931.
2. Harker LA, Marzec UM, Kelly AB, et al. Clopidogrel inhibition of stent, graft, and vascular thrombogenesis with antithrombotic enhancement by aspirin in nonhuman primates. Circulation 1998; 98 (22): 2461-2469.
3. Hillis LD, Smith PK, Anderson JL, et al. ACCF/AHA guideline for coronary artery bypass graft surgery: Executive summary: A report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines. Anesth Analg 2012; 114 (1): 11-45.
4. Stein PD, Schunemann HJ, Dalen JE, et al. Antithrombotic therapy in patients with saphenous vein and internal mammary artery bypass grafts: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126 (3 Suppl): 600S-608S.
5. http://www.ohri.ca/programs/clinical-epidemiology/oxford.asp.
6. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: Is blinding necessary ? Control Clin Trials 1996; 17 (1): 1-12.
7. Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Med 2009; 6 (7): e1000097.
8. Kulik A, Le May MR, Voisine P, et al. Aspirin plus clopidogrel versus aspirin alone after coronary artery bypass grafting: The clopidogrel after surgery for coronary artery disease (CASCADE) Trial. Circulation 2010; 122 (25): 2680-2687.
9. Mujanovic E, Nurkic M, Caluk J, et al. The effect of combined clopidogrel and aspirin therapy after off-pump coronary surgery: A pilot study. Innovations (Phila) 2009; 4 (5): 265-268.
10. Gao G, Zheng Z, Pi Y, et al. Aspirin plus clopidogrel therapy increases early venous graft patency after coronary artery bypass surgery a single-center, randomized, controlled trial. J Am Coll Cardiol 2010; 56 (20): 1639-1643.
11. Sun JC, Teoh KH, Lamy A, et al. Randomized trial of aspirin and clopidogrel versus aspirin alone for the prevention of coronary artery bypass graft occlusion: The Preoperative Aspirin and Postoperative Antiplatelets in Coronary Artery Bypass Grafting study. Am Heart J 2010; 160 (6): 1178-1184.
12. Mannacio VA, Di Tommaso L, Antignano A, et al. Aspirin plus clopidogrel for optimal platelet inhibition following off-pump coronary artery bypass surgery: Results from the CRYSSA (prevention of Coronary arteRY bypaSS occlusion after off-pump procedures) randomised study. Heart 2012; 98 (23): 1710-1715.
13. Halkos ME, Cooper WA, Petersen R, et al. Early administration of clopidogrel is safe after off-pump coronary artery bypass surgery. Ann Thorac Surg 2006; 81 (3): 815-819.
14. Friedrich JO, Adhikari NK, Beyene J:, Inclusion of zero total event trials in meta-analyses maintains analytic consistency and incorporates all available data. BMC Med Res Methodol 2007; 7: 5.
15. Higgins JPT, Green S:, Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011.
16. Gurbuz AT, Zia AA, Vuran AC, et al. Postoperative clopidogrel improves mid-term outcome after off-pump coronary artery bypass graft surgery: A prospective study. Eur J Cardiothorac Surg 2006; 29 (2): 190-195.
17. Chan V, Kulik A, Bourke ME, et al. Clopidogrel is safe early after on- and off-pump coronary artery bypass surgery. J Card Surg 2007; 22 (6): 493-497.
18. Kim DH, Daskalakis C, Silvestry SC, et al. Aspirin and clopidogrel use in the early postoperative period following on-pump and off-pump coronary artery bypass grafting. J Thorac Cardiovasc Surg 2009; 138 (6): 1377-1384.
19. Sanon S, Lee VV, Elayda M, et al. Use of aspirin versus clopidogrel plus aspirin after coronary artery bypass graft surgery. Clin Appl Thromb Hemost 2009; 15 (5): 540-544.
20. Sorensen R, Abildstrom SZ, Hansen PR, et al. Efficacy of post-operative clopidogrel treatment in patients revascularized with coronary artery bypass grafting after myocardial infarction. J Am Coll Cardiol 2011; 57 (10): 1202-1209.
21. Lorenz RL, Schacky CV, Weber M, et al. Improved aortocoronary bypass patency by low-dose aspirin (100 mg daily). Effects on platelet aggregation and thromboxane formation. Lancet 1984; 1 (8389): 1261-1264.
22. Chesebro JH, Fuster V, Elveback LR, et al. Effect of dipyridamole and aspirin on late vein-graft patency after coronary bypass operations. N Engl J Med 1984; 310 (4): 209-214.
23. Chesebro JH:, Acute coronary syndromes: Pathogenesis, acute diagnosis with risk stratification, and treatment. Am Heart Hosp J 2004; 2 (4 Suppl 1): 21-30.
24. Gasparovic H, Petricevic M, Kopjar T, et al. Dual antiplatelet therapy in patients with aspirin resistance following coronary artery bypass grafting: Study protocol for a randomized controlled trial [NCT01159639]. Trials 2012; 13 (1): 148.